Nicklaus Children’s Broadens Treatment Options for Congenital Heart Disease Patients with Minimally Invasive Therapy


Read Next

Related News

Speak Now for Kids Family Advocacy: Tad's Story
Over the last two years, Theodore “Tad” Hartrick has spent months at a time at Nicklaus Children’s Hospital. Like Tad, there are many children in the state and in the nation who rely on access to pediatric care and Medicaid funding. Here is a message from the Hartrick family in support of this year’s Speak Now For Kids Family Advocacy Week campaign.
The Heart Institute at Nicklaus Children's Acquires FDA-Approved Amplatzer Piccolo™ Occluder to Perform Non-Surgical Closures of Patent Ductus Arteriosus (PDA) in Premature Infants in its Cardiac Catheterization Laboratory
The Heart Institute now offers the recently FDA-approved Amplatzer Piccolo™ Occluder to close PDAs in very premature babies in the Cath Lab. This self-expanding, wire mesh device is designed specifically to fit within the PDA of very low weight preemies with little risk of interference with adjacent structures.

Related Press Releases

Nicklaus Children's Hospital Biobank Celebrates 500th Enrollment Milestone
The Nicklaus Children’s Hospital Biobank this summer enrolled its 500th participant, a significant milestone for the biorepository, founded in 2019 to address imbalances in genomic research, with the goal of enhancing individualized care for children in South Florida and beyond. The Biobank is part of the hospital’s Personalized Medicine Initiative, committed to harnessing the latest developments in genomic science.

 

Nicklaus Children's Hospital Earns 2021 CHIME Digital Health Most Wired Recognition
The College of Healthcare Information Management Executives (CHIME) is pleased to announce that Nicklaus Children’s Hospital has earned 2021 CHIME Digital Health Most Wired recognition as a certified acute level 7 hospital. The CHIME Digital Health Most Wired program conducts an annual survey to assess how healthcare organizations apply core and advanced technologies into their clinical and business programs.